Latest ABG-WTT Global Life Science Capital Partners GP Lt Stock Portfolio

$29.97Million

About ABG-WTT Global Life Science Capital Partners GP Lt and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, ABG-WTT Global Life Science Capital Partners GP Ltd reported an equity portfolio of $30 Millions as of 30 Jun, 2024.

The top stock holdings of ABG-WTT Global Life Science Capital Partners GP Ltd are , RPID, LUNG. The fund has invested 96.4% of it's portfolio in CG ONCOLOGY INC and 2.3% of portfolio in RAPID MICRO BIOSYSTEMS INC.

ABG-WTT Global Life Science Capital Partners GP Lt Equity Portfolio Value

Last Reported on: 14 Aug, 2024

New Buys

No new stocks were added by ABG-WTT Global Life Science Capital Partners GP Lt

Additions

No additions were made to existing positions by ABG-WTT Global Life Science Capital Partners GP Lt

Reductions

None of the existing positions were reduced by ABG-WTT Global Life Science Capital Partners GP Lt

Sold off

None of the stocks were completely sold off by ABG-WTT Global Life Science Capital Partners GP Lt

ABG-WTT Global Life Science Capital Partners GP Lt Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ABG-WTT Global Life Science Capital Partners GP Lt

Last Reported on: 14 Aug, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
LUNG	pulmonx corp	1.27	60,204	381,693	unchanged	0.00

RPID	rapid micro biosystems inc	2.29	1,038,300	685,275	unchanged	0.00

	cg oncology inc	96.44	915,501	28,902,400	unchanged	0.00